Hepatitis - number of persons initiated HCV treatment, latest year and cumulative over a period of years
Short name:
People on HCV treatment
Data type:
Count
Indicator Id:
3528
Topic:
Hepatitis
Hepatitis treatment and care
Health service coverage
Rationale:
WHO currently recommends treatment for all people with chronic hepatitis C to achieve hepatitis C cure. This indicator measures the number of people with hepatitis C who were evaluated for hepatitis disease progression and found to be eligible for and placed on treatment. This indicator is essential to measurement of the programmatic targets for the path to elimination and full validation of elimination of hepatitis C as a public health threat by 2030.
Definition:
Number of people diagnosed with chronic hepatitis C infection who have initiated HCV curative treatment in the given year and cumulatively since 2015
Disaggregation:
By country and WHO region
Method of measurement
Number of people with chronic HBV initiated treatment can be obtained from programme records (clinical records of health-care facilities providing hepatitis treatment and care) or drug supply management systems.
Patients receiving treatment in the private sector and public sector should be include.
M&E Framework:
Output
Method of estimation:
Data on treatment in low-income countries may not be easy to obtain if there is no centralized HBV treatment programme. Until nationwide data become easily available, extrapolation from select sites may be necessary. Additional data on treatment courses sold in the country (from pharmaceutical companies or pharmacies) could provide an indication of treatment coverage.
Method of estimation of global and regional aggregates:
Regional estimates are calculated as the sum of country level data in each of the WHO regions.
Preferred data sources:
Facility-based treatment registers or drug supply management systems
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.